Cerberus Therapeutics
PrivateLast Round
Strategic
Dec 5, 2023
Total Funding Raised
$9M
Company Overview
Cerberus Therapeutics is a biotechnology company that develops nanobody-based immunotherapy platforms for the treatment of autoimmune disorders and infectious diseases.
Sector
Healthcare & Life Sciences
Verticals
Biotechnology, Drug Discovery
Business Model
B2B
Customer Profile
Services & Consulting
AI Layer
Non-AI
Keywords
Historical Pricing
Historical view of private secondary pricing and transaction trends.
Cerberus Therapeutics Comparables
Compare Cerberus Therapeutics with similar companies based on industry and business-model similarity.
| Company | Similarity | Market Cap |
|---|---|---|
| FcR Therapeutics | 80% | |
| Kaigene Inc. | 77% | |
| ExeVir Bio | 77% |
Cerberus Therapeutics Funding Rounds
Historical fundraising activity
| Round | Date | Amount Raised | Valuation | Investors | Sources |
|---|---|---|---|---|---|
| Strategic | Dec 5, 2023 | ||||
| Seed | Dec 8, 2022 |
Key People
Founding team and executive leadership
Cerberus Therapeutics Investors
Notable investors and investment history
| Investor | Rounds |
|---|---|
| Gates Foundation | Strategic |
| Sherpa Healthcare Partners | Seed |
Market signals
Structured signals derived from secondary market and firmographic data.
- Nov 6, 2025
Monthly visitors increased 575% MoM to 6.4K.
- Jun 1, 2025
Monthly visitors increased 36% MoM.
Cerberus Therapeutics Filings
Explore SEC and related filing metadata, where available.
| Type | Date | Amount Offered | Amount Sold | Filing | Pages | Download |
|---|
Filing documents are not displayed on this public page. Request access to learn about available coverage.
Request accessFrequently Asked Questions
Common questions about Cerberus Therapeutics's valuation, stock price, and market status.
Is Cerberus Therapeutics a public or private company?
Cerberus Therapeutics is a private company.
What is the current stock price of Cerberus Therapeutics?
Cerberus Therapeutics is a private company with no public stock price. No recent secondary market data is available.
How much is Cerberus Therapeutics worth (valuation)?
Valuation information for Cerberus Therapeutics is not publicly available.
Can I buy Cerberus Therapeutics stock?
Cerberus Therapeutics shares may be available on secondary markets subject to transfer restrictions. Caplight facilitates secondary market transactions for accredited investors. Visit https://www.caplight.com to learn more.
When was Cerberus Therapeutics's last funding round?
Cerberus Therapeutics's most recent funding round was Strategic on December 5, 2023.
Who are the main investors in Cerberus Therapeutics?
Key investors in Cerberus Therapeutics include Gates Foundation, Sherpa Healthcare Partners.
Will Cerberus Therapeutics IPO soon?
No public IPO plans have been announced for Cerberus Therapeutics.
How can I track Cerberus Therapeutics secondary market activity?
Caplight tracks bids, offers, and trades for private companies. Visit https://www.caplight.com to monitor Cerberus Therapeutics's secondary market activity and sign up for updates.